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Commentary: 
Deconstructing the winding path to the recapitulation of mammalian 
oogenesis ex vivo       or 
Perseverance pays off in the ex vivo propagation of healthy 
mammalian oocytes   
David F. Albertini and Evelyn Telfer 
 
Producing functioning gametes for investigating the causes of human infertility is perhaps the highest 
goal on the regenerative medicine agenda.  Mammalian gametogenesis in males or females is a complex 
process wedding the generation of sex cells capable of supporting embryogenesis with events played 
out within the somatic confines of the testis or ovary. The path towards the completion of oogenesis 
requires a longstanding collaboration between somatic cells of the ovarian follicle that first engage 
primordial germ cells as they enter into meiotic prophase.   These newly formed oocytes come to rest 
within the primordial follicle pool to be siphoned off later during the adult reproductive lifespan. In this 
issue, Morohaku and colleagues deploy an elegant series of experimental manipulations that 
convincingly demonstrate how primordial germ cells in mice can be propagated through all stages of 
oogenesis and result in the production of healthy living offspring(1). On the pathway to deconstructing 
and reconstructing the pathway through oogenesis ex vivo, these investigations uncover several 
surprising details that will inform future studies aimed at defining the mechanisms underlying oogenesis 
and long awaited potential clinical applications. 
 
The road to their success begins in 1996 with studies coming from the Eppig laboratory establishing that 
functional oocytes could be developed from in vitro growth of primordial follicles (2) . Further 
refinements in their methodology improved efficiency for collection of differentiated oocytes (3). 
Importantly, work from the Eppig laboratory demonstrated the utility of reconstituting mouse ovarian 
somatic and germ cells in culture with eventual transplant experiments documenting the pluripotent 
capacity to generate a mammalian ovary capable of supporting follicle development (4).  But until 
publication of the Morohaku paper, all efforts to recapitulate oogenesis ex vivo have required 
complementation by tissue transplantation with limited success. 
An important clue came from the studies of Hayashi and colleagues in 2012(5). After coaxing mouse 
embryonic stem cells (ES) or induced pluripotent stem cells (iPSC) into a primordial germ cell-like state, 
they showed an age/stage-dependent requirement of the ovarian soma in order for the transplanted 
cells to become integrated into follicles capable of ovulating and producing oocytes with fertility 
potential, as shown by the birth of live young.  These studies and others emphasize the critical nature of 
an ongoing dialogue between ovarian somatic cells that invokes a panoply of signaling mechanisms 
necessary to establish and maintain oocyte/follicle development to its ultimate state, ovulation (6) (7). 
Indications from previous genetic manipulation studies identified key paracrine effectors at the interface 
between oocytes and somatic cells(8), but the extent to which these cues would be self-generating and 
operative in an in vitro culture system appeared to be problematic given the enormous complexity at 
specific stages (6) and the many extrinsic factors now known to influence the dialogue in vivo(9). A 
closer look at the pathway taken by Morohaku et al., suggests otherwise. 
Beginning with fetal 12.5 dpc ovaries, their initial studies hit an immediate roadblock when it was 
discovered that abnormal follicles emerged after 7-10 days of culture maintained in fetal bovine serum 
(FBS) but not an artificial serum substitute (SPS). Systematically narrowing the search for culprits led 
them to estradiol17B (E2) such that inclusion of an estrogen receptor antagonist in the culture medium 
encouraged sustained development of follicles whose enclosed oocytes proceeded through a 
hypertrophic growth phase only slightly less well than age-matched in vivo controls. From a technical 
perspective, two more obstacles were awaiting resolution that would be tested not only by 
morphological signs of normal development but would rely heavily on data obtained via RNA-seq  
serving the role of a GPS system guiding each step forward. So it was that inclusion of follicle-stimulating 
hormone (FSH) and 2% PVP as a cell interaction stabilizer between days 17 and 20 supported further 
growth and development and a whiff of collagenase over the last two weeks of culture (29-43 days in 
total) resulted in a formulation yielding healthy oocytes demonstrated to produce live young following 
in vitro fertilization and embryo transfer with conventional technology (Figure 1). 
What distinguishes this work from previous attempts to recapitulate oogenesis in vitro is not only the 
perseverance and attention to detail at each step along the road to fruition- live young-but the 
evaluation of oocyte quality parameters known from studies of mouse oogenesis in vivo to be critical for 
production of healthy oocytes. For example, this group long ago recognized that the competence to 
acquire and exercise completion of the process of meiosis took place during the growth phase of 
oogenesis and required epigenetic modifications in oocyte chromatin (10). Keep in mind that the 
processes of growth and transcriptional efficiency coupled to histone modifications required for the 
expression of housekeeping and maternal effect gene products (11) involve dynamic histone changes 
that precede imprinting methylations (12) .  Moreover, these stage specific methylation marks, of both  
imprinted and nonimprinted varieties, control later developmental events bearing directly on 
implantation and trophectoderm development (13).  Again, the paper by Mokoharu et al validates 
appropriate epigenetic modifications along the road to propagating the oocytes they document will give 
rise to healthy offspring. 
In many ways this paper reinforces the utility and intrinsic plasticity of the mouse model for future 
studies into the underpinnings of gametogenesis in the female as shown in previous investigations(14). 
But whether it sets the stage for moving in vitro gametogenesis into the realm of practical application in 
other mammalian species or clinical applications remains questionable (15). Any extrapolation to the 
human must be weighed against the significant differences in oocyte and follicle competence reported 
as a function of age (16) as wells as many major differences between mouse and human ovaries over the 
spectrum that is folliculogenesis (17, 18).  
In leaving no stone unturned, Morohaku and colleagues proffer an interesting twist towards the end of 
their report having to do with the feasibility of using cryopreserved ovaries and asking whether their 
system for propagating oocytes is applicable. Unsurprisingly, they show it is possible to generate 
developmentally competent oocytes from frozen fetal ovaries, albeit with less efficiency. With the field 
of fertility preservation steadily moving in the direction of artificial devices that could support oogenesis 
from primordial germ cells or stem cells (19), the clues provided from these studies on mice define a 
point of departure for future work aimed at accomplishing what Morokaru and colleagues have 
contributed to the field of in vitro gametogenesis. 
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Figure 1. Schematic summarizing the experimental system devised by Morohaky et al to obtain 
developmentally competent mouse oocytes in vitro. Main stages of follicle growth are shown at the top 
highlighting major transition events as they would occur during ovary development in vivo. Essential 
modifications to culture media are shown in red at the times corresponding to day of culture (blue table, 
bottom). Corresponding stage of in vivo ovarian development is shown below the time of culture. 
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